Literature DB >> 10090063

Characterization of platelet abnormalities of Tester Moriyama (TM) rats with storage pool deficiency.

H Fujimori1, K Ozaki, S Nomura, T Nishikawa, H Pan-Hou, M Nishimura, I Narama.   

Abstract

Platelet abnormalities of Tester Moriyama (TM) rats, which have prolonged bleeding time with normal platelet count, were characterized by comparison with those of fawn-hooded (FH) rats with platelet storage pool deficiency (SPD). Morphologically, the dense granules were virtually lacking in platelets from TM and FH rats. Platelets from TM and FH rats aggregated in response to adenosine diphosphate (ADP), but failed to have secondary aggregation. In contrast, platelet aggregation was completely absent in response to 1 to 20 micrograms of collagen/ml, although partial aggregation was observed at the higher dosage of 50 micrograms/ml. Normal amounts of platelet membrane glycoproteins IIb/IIIa were expressed in TM and FH rats, but platelet adenosine triphosphate (ATP) and ADP contents were lower than those in platelets from control Wistar rats. Platelet ATP-to-ADP ratio of TM and FH rats was significantly higher than that of Wistar rats. Serotonin content in platelets from TM and FH rats was 20 to 25% that of Wistar rat platelets. These results suggested that platelet abnormalities of TM rats are a typical characteristic of platelet SPD and are similar to those of FH rats, which are genetically different from TM rats. Therefore, TM rats may serve as a useful animal model for the study of platelet SPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10090063

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  2 in total

1.  The rat Ruby ( R) locus is Rab38: identical mutations in Fawn-hooded and Tester-Moriyama rats derived from an ancestral Long Evans rat sub-strain.

Authors:  Naoki Oiso; Suzette R Riddle; Tadao Serikawa; Takashi Kuramoto; Richard A Spritz
Journal:  Mamm Genome       Date:  2004-04       Impact factor: 2.957

2.  The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series).

Authors:  Margaret Mandy R MacLean
Journal:  Pulm Circ       Date:  2018 Apr-Jun       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.